IGF1 and Miyoshi myopathy: To assess the impact that IGF-I stimulation has on the activation of MV oncolysis, three MM cell lines were left untreated or treated with IGF-I (5 nM), MV-GFP (MOI 0.1) or treated with both agents (Figure 5A) and cell viability measured 24 hours later.